| |
| HDV |Abstract Library |
 |
| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
| Abstract Details |
 |
|
| |
| |
| |
|
|
| |
Current Knowledge on Hepatitis Delta Virus Replication |
|
|
|
|
| |
Antiviarl Res. 2020 Apr 29;179:104812. doi: 10.1016/j.antiviral.2020.104812.Online ahead of print.
Julie Lucifora 1, Marion Delphin 2
|
| |
|
|
| |
Author information
- 1INSERM, U1052, Cancer Research Center of Lyon (CRCL), Université de Lyon (UCBL1), CNRS UMR_5286, France. Electronic address: julie.lucifora@inserm.fr.
- 2INSERM, U1052, Cancer Research Center of Lyon (CRCL), Université de Lyon (UCBL1), CNRS UMR_5286, France.
Abstract
Hepatitis B Virus (HBV) that infects liver parenchymal cells is responsible for severe liver diseases and co-infection with Hepatitis Delta Virus (HDV) leads to the most aggressive form of viral hepatitis. Even tough being different for their viral genome (relaxed circular partially double stranded DNA for HBV and circular RNA for HDV), HBV and HDV are both maintained as episomes in the nucleus of infected cells and use the cellular machinery for the transcription of their viral RNAs. We propose here an update on the current knowledge on HDV replication cycle that may eventually help to identify new antiviral targets.
|
|
|
|
| |
| |
|
| |
|
|
|
|
|
